Regenerative potential of prostate luminal cells revealed by single-cell analysis

Author:

Karthaus Wouter R.1ORCID,Hofree Matan2ORCID,Choi Danielle1ORCID,Linton Eliot L.1ORCID,Turkekul Mesruh3ORCID,Bejnood Alborz2ORCID,Carver Brett1,Gopalan Anuradha1,Abida Wassim1ORCID,Laudone Vincent1,Biton Moshe2ORCID,Chaudhary Ojasvi4ORCID,Xu Tianhao4ORCID,Masilionis Ignas4ORCID,Manova Katia3ORCID,Mazutis Linas4ORCID,Pe’er Dana45,Regev Aviv267ORCID,Sawyers Charles L.16ORCID

Affiliation:

1. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

2. Klarman Cell Observatory, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.

3. Molecular Cytology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

4. Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

5. Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

6. Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

7. Koch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Abstract

Equal opportunity tissue regeneration Tissue regeneration is thought to be driven primarily by rare stem cells with distinctive properties. Single-cell RNA sequencing allows rigorous testing of this hypothesis. Karthaus et al. examined the regeneration of normal prostate tissue in mice after androgen ablation, a common treatment for prostate cancer (see the Perspective by Kelly). Unexpectedly, they found that in addition to rare stem cells, a large population of differentiated cells was a major contributor to prostate regeneration, a result that they confirmed in a study of human prostate tissue. Investigation of the molecular mechanism by which the differentiated cells acquired regenerative potential yielded insights that could potentially lead to improved therapies for prostate cancer. Science , this issue p. 497 ; see also p. 467

Funder

Howard Hughes Medical Institute

National Cancer Institute

Starr Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 158 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3